Specialty

Report

Immune checkpoint inhibitor medications: A game-changer in cancer treatments

A report from the Evernorth Research Institute offers insights that can help health plans optimize cancer care.

March 27, 25

Article

Specialty pipeline perspectives: The upcoming wave of biosimilars

Evernorth anticipates a dramatic shift in inflammatory and oncology treatments over the next five years, with dozens of biosimilars in the pipeline.

March 26, 25

Article

A journey through infertility: Jillian's story

By sharing her experience, Jillian hopes to encourage others to seek help and feel comfortable discussing their struggles.

March 12, 25

Article

Addressing health disparities in cancer care

Employers can take the lead in addressing health disparities and implementing strategies to serve vulnerable populations.

Kasey Raetz, PharmD, March 04, 25

Article

A specialty pharmacy team that delivers – even in inclement weather

February 25, 2025

Evernorth’s Express Scripts Specialty Distribution Services team went above and beyond to ensure patients were able to access their medications during a recent snowstorm.

Report

More cervical cancer screenings. More lives saved.

Improving access to regular cervical cancer screenings, especially for women in underserved communities, is key to reducing mortality rates.

Roseleen Charania, MD, February 25, 25